受试者-话题@MedSci

#受试者#

68篇内容 | 2576人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1446102, encodeId=a161144610216, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=JCC：回肠和结肠组织中miRNA表达的差异性揭示了克罗恩氏病患者与健康受试者之间免疫调节分子特征的不同, objectType=article, longId=182739, objectId=f1e8182e3911, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1e8182e3911, replyNumber=0, likeNumber=80, createdTime=2019-11-10, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1e8182e3911, moduleTitle=JCC：回肠和结肠组织中miRNA表达的差异性揭示了克罗恩氏病患者与健康受试者之间免疫调节分子特征的不同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1e8182e3911)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446101, encodeId=93f7144610136, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=GSK资助的呼吸道合胞病毒新疫苗研究，正在招收婴儿受试者以免受致死的肺部感染, objectType=article, longId=180630, objectId=8fdd18063032, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fdd18063032, replyNumber=0, likeNumber=82, createdTime=2019-10-09, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fdd18063032, moduleTitle=GSK资助的呼吸道合胞病毒新疫苗研究，正在招收婴儿受试者以免受致死的肺部感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fdd18063032)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446100, encodeId=f1c41446100c6, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=强生的HIV预防性疫苗Imbokodo已经完成临床受试者的招募, objectType=article, longId=167493, objectId=435a16e49305, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=435a16e49305, replyNumber=0, likeNumber=75, createdTime=2019-06-03, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=435a16e49305, moduleTitle=强生的HIV预防性疫苗Imbokodo已经完成临床受试者的招募, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=435a16e49305)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446099, encodeId=93581446099d0, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=从受试者到合作方，基于「患者交互」的临床试验新模式, objectType=article, longId=166044, objectId=5a0c1660447b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a0c1660447b, replyNumber=0, likeNumber=73, createdTime=2019-05-15, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a0c1660447b, moduleTitle=从受试者到合作方，基于「患者交互」的临床试验新模式, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a0c1660447b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446098, encodeId=12b2144609849, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=AAN：Immunovant宣布其用于治疗重症肌无力的抗FcRn单抗IMVT-1401，在健康受试者中耐受良好, objectType=article, longId=165921, objectId=14c71659215e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14c71659215e, replyNumber=0, likeNumber=59, createdTime=2019-05-14, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14c71659215e, moduleTitle=AAN：Immunovant宣布其用于治疗重症肌无力的抗FcRn单抗IMVT-1401，在健康受试者中耐受良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14c71659215e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446097, encodeId=9259144609e51, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=Eur Arch Otorhinolaryngol：健康受试者中应激刺激的鼻响应研究, objectType=article, longId=160899, objectId=60fb160899ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60fb160899ba, replyNumber=0, likeNumber=58, createdTime=2019-02-25, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60fb160899ba, moduleTitle=Eur Arch Otorhinolaryngol：健康受试者中应激刺激的鼻响应研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60fb160899ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446096, encodeId=b98b1446096d4, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=抗肿瘤药物临床试验中的受试者管理, objectType=article, longId=155677, objectId=4bd81556e74f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bd81556e74f, replyNumber=0, likeNumber=57, createdTime=2018-12-14, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bd81556e74f, moduleTitle=抗肿瘤药物临床试验中的受试者管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bd81556e74f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446095, encodeId=3b171446095a3, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=Hypertension：高血压和非高血压受试者收缩压与脑灌注的不同关系, objectType=article, longId=153419, objectId=7d871534190b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d871534190b, replyNumber=0, likeNumber=94, createdTime=2018-11-15, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d871534190b, moduleTitle=Hypertension：高血压和非高血压受试者收缩压与脑灌注的不同关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d871534190b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446094, encodeId=2dd7144609409, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=Diabetes Care：1型糖尿病、MODY2和健康对照受试者肠道微生物群的组成和功能有所不同, objectType=article, longId=149059, objectId=3c6f14905959, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c6f14905959, replyNumber=0, likeNumber=75, createdTime=2018-09-20, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c6f14905959, moduleTitle=Diabetes Care：1型糖尿病、MODY2和健康对照受试者肠道微生物群的组成和功能有所不同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c6f14905959)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446093, encodeId=3e3e1446093da, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=JAHA：皮肤自发荧光衡量的晚期糖基化终产物可作为高风险受试者心血管和全因死亡率的预测因子, objectType=article, longId=148522, objectId=72b61485221d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72b61485221d, replyNumber=0, likeNumber=70, createdTime=2018-09-11, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72b61485221d, moduleTitle=JAHA：皮肤自发荧光衡量的晚期糖基化终产物可作为高风险受试者心血管和全因死亡率的预测因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72b61485221d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446092, encodeId=60c21446092df, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=CCLM：在健康受试者中估计红细胞和网织红细胞参数的短期和中期生物学变异, objectType=article, longId=144610, objectId=369e14461092, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=369e14461092, replyNumber=0, likeNumber=58, createdTime=2018-07-19, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=369e14461092, moduleTitle=CCLM：在健康受试者中估计红细胞和网织红细胞参数的短期和中期生物学变异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=369e14461092)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446091, encodeId=5ae6144609144, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=Clinical and translation gastroenterology：口服丁酸盐治疗在精瘦患者与代谢综合征受试者中的代谢作用有差异, objectType=article, longId=139567, objectId=7f4713956e6f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f4713956e6f, replyNumber=0, likeNumber=60, createdTime=2018-06-02, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f4713956e6f, moduleTitle=Clinical and translation gastroenterology：口服丁酸盐治疗在精瘦患者与代谢综合征受试者中的代谢作用有差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f4713956e6f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446090, encodeId=778614460902f, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=Microvasc Res：健康和糖尿病视网膜病变受试者中结膜微血管血流动力学测量的时间变化！, objectType=article, longId=130053, objectId=2cdf1300536a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cdf1300536a, replyNumber=0, likeNumber=101, createdTime=2018-02-17, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cdf1300536a, moduleTitle=Microvasc Res：健康和糖尿病视网膜病变受试者中结膜微血管血流动力学测量的时间变化！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cdf1300536a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446089, encodeId=1a49144608998, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=EJCP：阿瑞匹坦（一种中度CYP3A4抑制剂）对健康受试者中的bosutinib暴露的影响, objectType=article, longId=124479, objectId=7f411244e9c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f411244e9c2, replyNumber=0, likeNumber=53, createdTime=2017-12-26, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f411244e9c2, moduleTitle=EJCP：阿瑞匹坦（一种中度CYP3A4抑制剂）对健康受试者中的bosutinib暴露的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f411244e9c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446088, encodeId=d6831446088ff, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=精神医学试验如何保护受试者权益, objectType=article, longId=121785, objectId=5f64121e85cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f64121e85cd, replyNumber=0, likeNumber=61, createdTime=2017-12-01, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f64121e85cd, moduleTitle=精神医学试验如何保护受试者权益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f64121e85cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446087, encodeId=d581144608e3a, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=诺华ACZ885在III期临床试验CANTOS受试者亚组中降低心血管风险25%, objectType=article, longId=120485, objectId=e3de120485e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3de120485e7, replyNumber=0, likeNumber=71, createdTime=2017-11-19, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3de120485e7, moduleTitle=诺华ACZ885在III期临床试验CANTOS受试者亚组中降低心血管风险25%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3de120485e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446086, encodeId=b53f1446086b9, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=CCLM：血液透析患者和健康受试者中甲状旁腺素的稳定性如何？, objectType=article, longId=107822, objectId=24da10e822fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24da10e822fd, replyNumber=0, likeNumber=57, createdTime=2017-08-07, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24da10e822fd, moduleTitle=CCLM：血液透析患者和健康受试者中甲状旁腺素的稳定性如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24da10e822fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446085, encodeId=775f1446085c7, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=Diabetes：在精瘦和肥胖受试者中肥胖抑制素对血管的影响！, objectType=article, longId=92340, objectId=613892340f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=613892340f9, replyNumber=0, likeNumber=89, createdTime=2017-03-20, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=613892340f9, moduleTitle=Diabetes：在精瘦和肥胖受试者中肥胖抑制素对血管的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=613892340f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446084, encodeId=37e514460842c, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=2016药物临床试验受试者招募·广东共识发布, objectType=article, longId=78112, objectId=057ae8112f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=057ae8112f8, replyNumber=0, likeNumber=39, createdTime=2016-09-23, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=057ae8112f8, moduleTitle=2016药物临床试验受试者招募·广东共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=057ae8112f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446083, encodeId=5c1a1446083e5, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=法国临床研究受试者死亡事件解析, objectType=article, longId=62396, objectId=329c623966b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=329c623966b, replyNumber=0, likeNumber=40, createdTime=2016-01-23, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=329c623966b, moduleTitle=法国临床研究受试者死亡事件解析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=329c623966b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

受试者

2020-05-29

xinmeili (审核中...)

前往app查看评论内容

#受试者#

JCC：回肠和结肠组织中miRNA表达的差异性揭示了克罗恩氏病患者与健康受试者之间免疫调节分子特征的不同

2019-11-10

xinmeili (审核中...)

前往app查看评论内容

#受试者#

GSK资助的呼吸道合胞病毒新疫苗研究，正在招收婴儿受试者以免受致死的肺部感染

2019-10-09

xinmeili (审核中...)

前往app查看评论内容

#受试者#

强生的HIV预防性疫苗Imbokodo已经完成临床受试者的招募

2019-06-03

xinmeili (审核中...)

前往app查看评论内容

#受试者#

从受试者到合作方，基于「患者交互」的临床试验新模式

2019-05-15

xinmeili (审核中...)

前往app查看评论内容

#受试者#

AAN：Immunovant宣布其用于治疗重症肌无力的抗FcRn单抗IMVT-1401，在健康受试者中耐受良好

2019-05-14

xinmeili (审核中...)

前往app查看评论内容

#受试者#

Eur Arch Otorhinolaryngol：健康受试者中应激刺激的鼻响应研究

2019-02-25

xinmeili (审核中...)

前往app查看评论内容

#受试者#

抗肿瘤药物临床试验中的受试者管理

2018-12-14

xinmeili (审核中...)

前往app查看评论内容

#受试者#

Hypertension：高血压和非高血压受试者收缩压与脑灌注的不同关系

2018-11-15

xinmeili (审核中...)

前往app查看评论内容

#受试者#

Diabetes Care：1型糖尿病、MODY2和健康对照受试者肠道微生物群的组成和功能有所不同

2018-09-20

hb2008ye (审核中...)

前往app查看评论内容

#受试者#

JAHA：皮肤自发荧光衡量的晚期糖基化终产物可作为高风险受试者心血管和全因死亡率的预测因子

2018-09-11

xinmeili (审核中...)

前往app查看评论内容

#受试者#

CCLM：在健康受试者中估计红细胞和网织红细胞参数的短期和中期生物学变异

2018-07-19

xinmeili (审核中...)

前往app查看评论内容

#受试者#

Clinical and translation gastroenterology：口服丁酸盐治疗在精瘦患者与代谢综合征受试者中的代谢作用有差异

2018-06-02

xinmeili (审核中...)

前往app查看评论内容

#受试者#

Microvasc Res：健康和糖尿病视网膜病变受试者中结膜微血管血流动力学测量的时间变化！

2018-02-17

xinmeili (审核中...)

前往app查看评论内容

#受试者#

EJCP：阿瑞匹坦（一种中度CYP3A4抑制剂）对健康受试者中的bosutinib暴露的影响

2017-12-26

xinmeili (审核中...)

前往app查看评论内容

#受试者#

精神医学试验如何保护受试者权益

2017-12-01

xinmeili (审核中...)

前往app查看评论内容

#受试者#

诺华ACZ885在III期临床试验CANTOS受试者亚组中降低心血管风险25%

2017-11-19

xinmeili (审核中...)

前往app查看评论内容

#受试者#

CCLM：血液透析患者和健康受试者中甲状旁腺素的稳定性如何？

2017-08-07

xinmeili (审核中...)

前往app查看评论内容

#受试者#

Diabetes：在精瘦和肥胖受试者中肥胖抑制素对血管的影响！

2017-03-20

xinmeili (审核中...)

前往app查看评论内容

#受试者#

2016药物临床试验受试者招募·广东共识发布

2016-09-23

xinmeili (审核中...)

前往app查看评论内容

#受试者#

法国临床研究受试者死亡事件解析

2016-01-23

科室
- - 订阅+
  - 更多科室
工具
服务